Clinical trial
Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up
NCT06143137 is registered in ClinicalTrials.gov with Artcline GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up
- Lead sponsor
- Artcline GmbH
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 1, 2024
- Completion date
- February 28, 2030
- Enrollment
- 142 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
severe sepsis